# Potential impact of urolithin A on pathways relevant to sleep health: a mini review

**Authors:** Ana Clara da C. Pinaffi-Langley, Faris M. Zuraikat, Marie-Pierre St-Onge, Andriy Yabluchanskiy

PMC · DOI: 10.3389/fnut.2026.1779855 · Frontiers in Nutrition · 2026-03-04

## TL;DR

This review explores how urolithin A, a gut microbiota metabolite, may influence sleep health through various biological pathways.

## Contribution

The paper introduces urolithin A as a potential novel target in polyphenol-derived microbial metabolite research for sleep health.

## Key findings

- Urolithin A may influence sleep-relevant pathways through modulation of the central clock and gut microbiota.
- Preclinical studies suggest urolithin A could protect against neuroinflammation caused by sleep deprivation.
- Further studies using specific sleep measures are needed to confirm direct effects of urolithin A on sleep.

## Abstract

Sleep is vital to human health, and poor sleep health has been associated with numerous chronic conditions, including cardiovascular disease, obesity, depression, and type 2 diabetes. Recently, an emerging area of research has focused on the relationship between dietary polyphenols and sleep health. This connection may be mediated by the gut microbiota and polyphenol-derived microbial metabolites, which also exert biologically relevant effects. One such metabolite, urolithin A, has been shown to improve mitochondrial function, muscle strength, and inflammation in humans. However, its potential effect on sleep remains unexplored. Thus, this mini review aimed to summarize the current evidence on the effect of urolithin A on sleep-relevant pathways and to explore the possible mechanisms underlying this effect. Although no study directly investigating the effect of urolithin A on sleep outcomes was identified, our search found four preclinical studies that included outcomes relevant to sleep. These studies provide mechanistic plausibility for the relationship between urolithin A and sleep health through direct and indirect mechanisms such as modulation of the central clock, protection against neuroinflammation caused by sleep deprivation, and modulation of the gut microbiota. However, to elucidate the direct effect of urolithin A on sleep, studies with specific sleep measures such as electroencephalogram, actigraphy, and/or polysomnography are still required. Taken together, this represents a novel direction in polyphenol-derived microbial metabolite research with many opportunities for future research.

## Linked entities

- **Chemicals:** urolithin A (PubChem CID 5488186)
- **Diseases:** cardiovascular disease (MONDO:0004995), obesity (MONDO:0011122), depression (MONDO:0002050), type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Diseases:** sleep deprivation (MESH:D012892), inflammation (MESH:D007249), type 2 diabetes (MESH:D003924), obesity (MESH:D009765), depression (MESH:D003866), neuroinflammation (MESH:D000090862), cardiovascular disease (MESH:D002318)
- **Chemicals:** polyphenol (MESH:D059808), urolithin A (MESH:C026423)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12995754/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12995754/full.md

## References

76 references — full list in the complete paper: https://tomesphere.com/paper/PMC12995754/full.md

---
Source: https://tomesphere.com/paper/PMC12995754